Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

Core Insights - Cue Biopharma, Inc. is participating in the Citizens Life Sciences Conference on May 7-8, 2025, to discuss its advancements in therapeutic biologics targeting T cells for autoimmune diseases and cancer [1][2] Company Overview - Cue Biopharma is a clinical-stage biopharmaceutical company focused on developing a novel class of injectable biologics that selectively engage and modulate disease-specific T cells within the patient's body [4] - The company's proprietary platform, Immuno-STAT™, aims to harness the body's immune system's curative potential while minimizing adverse effects associated with broad systemic immune modulation [4] Conference Details - The presentation at the Citizens Life Sciences Conference is scheduled for May 8, 2025, from 11:00 a.m. to 11:25 a.m. EDT, featuring CEO Daniel Passeri [3] - A live and archived webcast of the fireside chat will be available on the company's website for 30 days [3]